Skip to main content
. 2015 Jan 27;19(3):664–675. doi: 10.1111/jcmm.12382

Table 2.

All clinical responses achieved by each treatment in each histotype

Subject information Tumour Information
Age (years) Gender Breed Histotype Location Previous treatment Best response
12 Male Tibetan Terrier AA Oral (Mandible) Radiation (2×) PR
10 Female German Shepherd AA Oral (Mandible) None PR
10 Male Black Labrador Retriever SCC/PC Cutaneous (Limb)/Oral (Soft Pallete) Surgery/None CR/PR
9 Male Chihuahua SCC Oral (Mandible) None SD
8 Male Mixed SCC Oral (Maxillary Buccal) Surgery + Radiation CR
9 Male Jack Russel Terrier SCC Oral (Retromolar Trigone) None PR
10 Female German Shepherd SCC Oral (Lingual) Surgery PR
12 Male Black Labrador Retriever SCC Nasal Plenum Radiation (2×) SD
9 Male Yellow Labrador Retriever SCC Nasal Plenum Radiation SD
9 Female Rough Collie Sarcoma Subcutaneous (Frontal Orbital) Surgery + Radiation PD
10 Male Mix Sarcoma Subcutaneous (Limb) Surgery SD
12 Male Dachsund Sarcoma Oral (Mandible) None PD
8 Female Doberman Pinscher Sarcoma Subcutaneous (Limb) Radiation (2×) SD